Science
Mechanism of Action
Topically applied, it converts to Protoporphyrin IX (PpIX), a potent photosensitizer. Exposure to specific wavelengths (blue 400-450nm or red 630-635nm) triggers a photodynamic reaction, generating cytotoxic oxygen species that selectively destroy targeted cells.
Research
Clinical Evidence
High confidenceN/A
Key findings
- 01 Superior to vehicle for clearing actinic keratosis (AK) lesions on upper extremities.
- 02 Achieved significant lesion clearance in AK when used with blue light photoactivation.
- 03 Achieved 100% histological and clinical clearance of facial cutaneous squamous cell carcinoma in situ (SCCis) using red light PDT.
Transparency
Dusting Analysis
This ingredient is regulated as a drug and is not typically used in cosmetic formulations in sub-effective concentrations. Its application is for specific medical treatments.
The Formula
Formulation
Stability
Highly unstable at physiological pH (near 7.4), undergoing dimerization. Stability is enhanced at acidic pH (<5.0) or when formulated in nanoemulsions/lipid vesicles.
Conflicts
- Known photosensitizing agents (e.g., tetracyclines, thiazides, sulfonamides)
- High pH environments
- Bright light exposure (pre-treatment)
Safety
Safety Profile
Primarily regulated as an FDA-approved drug for Photodynamic Therapy. Not traditionally used as a general cosmetic ingredient due to high photosensitivity risks, potential for transient stinging, burning, erythema, and edema upon light exposure.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While highly effective in medically supervised photodynamic therapy for specific dermatological conditions, its drug classification and significant photosensitivity risks make it unsuitable for general cosmetic application.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources